- Home
- AUPH vs KSS Comparison
AUPH vs KSS Comparison
Compare AUPH & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | KSS |
|---|---|---|
| Founded | 1993 | 1962 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AUPH | KSS |
|---|---|---|
| Price | $15.44 | $18.51 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 4 | 15 |
| Target Price | ★ $17.25 | $15.31 |
| AVG Volume (30 Days) | 1.4M | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | ★ 5075.00 | 142.86 |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | N/A |
| Revenue Next Year | $15.74 | $0.21 |
| P/E Ratio | $61.40 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $8.80 | $10.33 |
| 52 Week High | $19.25 | $25.22 |
Technical Indicators
Market Signals| Indicator | AUPH | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 58.00 |
| Support Level | $15.43 | $17.06 |
| Resistance Level | $16.38 | $19.19 |
| Average True Range (ATR) | 0.55 | 0.89 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 29.59 | 81.27 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About KSS Kohl's Corporation
Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.